Publications by authors named "Arjun V Balar"

30Publications

Outcomes With First-line PD-1/PD-L1 Inhibition in Advanced Urothelial Cancer: A Single Institution Experience.

Clin Genitourin Cancer 2020 06 16;18(3):e209-e216. Epub 2019 Oct 16.

Perlmutter Cancer Center, New York University, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2019.10.001DOI Listing
June 2020

Pembrolizumab in the treatment of locally advanced or metastatic urothelial carcinoma: clinical trial evidence and experience.

Ther Adv Urol 2019 Jan-Dec;11:1756287219839285. Epub 2019 Apr 4.

Associate Professor of Medicine, Director, Genitourinary Medical Oncology Program, Laura and Isaac Perlmutter Cancer Center, NYU Langone Health, 160 East 34th Street, 10th Floor, New York, NY 10016, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1756287219839285DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6452591PMC
April 2019

PD-1/PD-L1 Combinations in Advanced Urothelial Cancer: Rationale and Current Clinical Trials.

Clin Genitourin Cancer 2019 06 29;17(3):e618-e626. Epub 2019 Mar 29.

New York University Perlmutter Cancer Center, New York, NY.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15587673183068
Publisher Site
http://dx.doi.org/10.1016/j.clgc.2019.03.009DOI Listing
June 2019

Recent Clinical Trials Explore Immunotherapies for Urothelial Carcinoma.

Authors:
Arjun V Balar

Oncology (Williston Park) 2019 Apr;33(4):132-6

View Article

Download full-text PDF

Source
April 2019

Current Status and Future Direction of Immunotherapy in Urothelial Carcinoma.

Curr Oncol Rep 2019 02 26;21(3):24. Epub 2019 Feb 26.

Department of Medicine, NYU School of Medicine, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11912-019-0775-5DOI Listing
February 2019

Multicenter Prospective Phase II Trial of Neoadjuvant Dose-Dense Gemcitabine Plus Cisplatin in Patients With Muscle-Invasive Bladder Cancer.

J Clin Oncol 2018 07 9;36(19):1949-1956. Epub 2018 May 9.

Gopa Iyer, Bernard H. Bochner, Guido Dalbagni, S. Machele Donat, Harry W. Herr, Irina Ostrovnaya, Hikmat Al-Ahmadie, Maria E. Arcila, Jamie C. Riches, Andreas Meier, Caitlin Bourque, Maha Shady, Helen Won, Brooke E. Kania, Mariel E. Boyd, Catharine K. Cipolla, Ashley M. Regazzi, Asia S. McCoy, Hebert Alberto Vargas, Michael F. Berger, David B. Solit, Jonathan E. Rosenberg, and Dean F. Bajorin, Memorial Sloan Kettering Cancer Center; Gopa Iyer, Bernard H. Bochner, Guido Dalbagni, S. Machele Donat, Harry W. Herr, Hikmat Al-Ahmadie, David B. Solit, and Dean F. Bajorin, Weill Cornell Medical College; Arjun V. Balar, William C. Huang, Samir S. Taneja, and Daniela Delbeau, New York University Langone Medical Center, New York, NY; and Matthew I. Milowsky, Michael Woods, Tracy L. Rose, and William Y. Kim, University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.75.0158DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6049398PMC
July 2018

Prospective Pilot Study to Evaluate the Incremental Value of PET Information in Patients With Bladder Cancer Undergoing 18F-FDG Simultaneous PET/MRI.

Clin Nucl Med 2017 Jan;42(1):e8-e15

From the *Department of Radiology, †Division of Urologic Oncology, Department of Urology, and ‡Division of Hematology and Oncology, Department of Medicine, NYU Langone Medical Center, New York, NY.

View Article

Download full-text PDF

Source
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/RLU.0000000000001432DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5538348PMC
January 2017

Multidisciplinary care of the urothelial cancer patient.

Urol Clin North Am 2015 May;42(2):xiii

Genitourinary Oncology, Urologic Oncology Program, UNC Lineberger Comprehensive Cancer Center, Division of Hematology/Oncology, 3rd Floor, Physician's Office Building, 170 Manning Drive, Chapel Hill, NC 27599, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ucl.2015.03.001DOI Listing
May 2015

Neoadjuvant therapy in muscle-invasive bladder cancer: a model for rational accelerated drug development.

Urol Clin North Am 2015 May 11;42(2):217-24, viii-ix. Epub 2015 Mar 11.

Genitourinary Oncology, Urologic Oncology Program, UNC Lineberger Comprehensive Cancer Center, 3rd Floor Physician's Office Building, 170 Manning Drive, Chapel Hill, NC 27599, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ucl.2015.02.004DOI Listing
May 2015

Comparison of Coregistration Accuracy of Pelvic Structures Between Sequential and Simultaneous Imaging During Hybrid PET/MRI in Patients with Bladder Cancer.

Clin Nucl Med 2015 Aug;40(8):637-41

From the *Department of Radiology, †Division of Hematology and Oncology, Department of Medicine, and ‡Division of Urologic Oncology, Department of Urology, NYU Langone Medical Center, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/RLU.0000000000000772DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494885PMC
August 2015

Whole-lesion diffusion metrics for assessment of bladder cancer aggressiveness.

Abdom Imaging 2015 Feb;40(2):327-32

Department of Radiology, NYU Langone Medical Center, 550 First Avenue, New York, NY, 10016, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00261-014-0213-yDOI Listing
February 2015

Cytotoxic and DNA-targeted therapy in urothelial cancer: have we squeezed the lemon enough?

Cancer 2015 Jan 4;121(2):179-87. Epub 2014 Aug 4.

Genitourinary Cancers Program, Perlmutter Cancer Center, NYU Langone Medical Center, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.28754DOI Listing
January 2015

The impact of taxanes on the management of genitourinary cancers.

Authors:
Arjun V Balar

Anticancer Drugs 2014 May;25(5):555-60

NYU Clinical Cancer Center, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CAD.0000000000000088DOI Listing
May 2014

Phase II study of everolimus in metastatic urothelial cancer.

BJU Int 2013 Aug 3;112(4):462-70. Epub 2013 Apr 3.

Genitourinary Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1464-410X.2012.11720.xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4020005PMC
August 2013

Novel agents in invasive urothelial cancer.

Clin Adv Hematol Oncol 2012 Aug;10(8):504-16

Memorial Sloan-Kettering Cancer Center, New York, New York.

View Article

Download full-text PDF

Source
August 2012